Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Competing Risks in Patients with Primary Prevention Implantable Cardioverters Defibrillators: Global Electrical Heterogeneity and Clinical Outcomes (GEHCO) Study

Jonathan W. Waks, Kazi T. Haq, Christine Tompkins, Albert J. Rogers, Ashkan Ehdaie, Aron Bender, Jessica Minnier, Khidir Dalouk, Stacey Howell, Achille Peiris, Merritt Raitt, Sanjiv M. Narayan, Sumeet S. Chugh, View ORCID ProfileLarisa G. Tereshchenko
doi: https://doi.org/10.1101/2020.12.16.20248369
Jonathan W. Waks
1Beth Israel Deaconess Medical Center, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazi T. Haq
2Oregon Health & Science University, Knight Cardiovascular Institute, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christine Tompkins
3University of Colorado, Aurora, CO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert J. Rogers
4Stanford University School of Medicine, Palo Alto, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashkan Ehdaie
5Cedars-Sinai Health System, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aron Bender
2Oregon Health & Science University, Knight Cardiovascular Institute, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Minnier
2Oregon Health & Science University, Knight Cardiovascular Institute, Portland, OR
6Oregon Health & Science University, OHSU-PSU School of Public Health, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Khidir Dalouk
7VA Portland Health Care System, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stacey Howell
2Oregon Health & Science University, Knight Cardiovascular Institute, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Achille Peiris
5Cedars-Sinai Health System, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Merritt Raitt
7VA Portland Health Care System, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjiv M. Narayan
4Stanford University School of Medicine, Palo Alto, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sumeet S. Chugh
5Cedars-Sinai Health System, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Larisa G. Tereshchenko
2Oregon Health & Science University, Knight Cardiovascular Institute, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Larisa G. Tereshchenko
  • For correspondence: tereshch@ohsu.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Global electrical heterogeneity (GEH) is associated with sudden cardiac death in the general population.

Objective To investigate whether GEH is associated with sustained ventricular tachycardia (VT)/ventricular fibrillation (VF) leading to appropriate implantable cardioverter-defibrillator (ICD) therapies in systolic heart failure (HF) patients with primary prevention ICDs.

Methods We conducted a multicenter retrospective cohort study. GEH was measured by spatial ventricular gradient (SVG) direction and magnitude, QRS-T angle, and sum absolute QRST integral (SAIQRST) on pre-implant 12-lead ECGs. Survival analysis using cause-specific hazard functions compared the strength of associations with two competing outcomes: sustained VT/VF leading to appropriate ICD therapies and all-cause death without appropriate ICD therapies.

Results We analyzed data from 2,668 patients (age 63±12y; 23% female; 78% white; 43% nonischemic cardiomyopathy (NICM); left ventricular ejection fraction 28±11% from 6 academic medical centers). After adjustment for demographic, clinical, device, and traditional ECG characteristics, SVG elevation (Hazard Ratio (HR) per 1 standard deviation (SD) 1.14 (95% CI 1.04-1.25); P=0.004), SVG azimuth (HR 1.12(1.01-1.24); P=0.039); SVG magnitude (HR per 1 SD 0.75 (0.66-0.85); P<0.0001), and QRS-T angle (HR per 1 SD 1.21 (95% CI 1.08-1.36); P=0.001) were associated with appropriate ICD therapies. The SVG azimuth was also associated with a lower competing risk of death (Pdifference=0.007): HR 0.91(0.82-1.02); P=0.095. SAIQRST had different associations in ischemic [HR 1.29(1.04-1.60)] and NICM [HR 0.78(0.62-0.96); Pinteraction=0.022].

Conclusion In patients with primary prevention ICDs, GEH is independently associated with appropriate ICD therapies. The SVG vector points in distinctly different directions in patients with two competing outcomes.

Clinical Trial Registration URL:www.clinicaltrials.gov Unique identifier: NCT03210883.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

URL:www.clinicaltrials.gov Unique identifier: NCT03210883

Clinical Protocols

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556174/

Funding Statement

This study was funded through the AHA Grant-In-Aid #17GRNT33670428 (LGT) and partially HL118277 (LGT).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The multicenter study has been approved by the OHSU Institutional Review Board (IRB). In addition, each participating center obtained local IRB approval prior to participating.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • We added 3 new figures (1, 4, and 5), added analysis of the interaction with cardiomyopathy type, and expanded Discussion.

Data Availability

The data will be available through the National Heart, Lung, and Blood Institute Biological Specimen and Data Repository Information Coordinating Center (BioLINCC) after the publication of this manuscript (planning submission). The open-source MATLAB (MathWorks, Natick, MA, USA) code for ECG analysis is provided at https://physionet.org/physiotools/geh and https://github.com/Tereshchenkolab/Origin. Statistical analysis code is provided at https://github.com/Tereshchenkolab/statistics.

https://physionet.org/physiotools/geh

https://github.com/Tereshchenkolab/Origin

https://github.com/Tereshchenkolab/statistics

  • Abbreviations

    CM
    cardiomyopathy
    LVEF
    left ventricular ejection fraction
    SCD
    sudden cardiac death
    ICD
    implantable cardioverter-defibrillator
    NYHA
    New York Heart Association
    HF
    heart failure
    ICM
    ischemic/infarct-related cardiomyopathy
    NICM
    nonischemic cardiomyopathy
    GEH
    global electrical heterogeneity
    SVG
    spatial ventricular gradient
    CRT-D
    cardiac resynchronization therapy defibrillator
    PVC
    premature ventricular complex
    SAIQRST
    sum absolute QRST integral
    VMQTi
    QT integral on vector magnitude signal
    NID
    number of intervals to detect
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted December 29, 2020.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Competing Risks in Patients with Primary Prevention Implantable Cardioverters Defibrillators: Global Electrical Heterogeneity and Clinical Outcomes (GEHCO) Study
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Competing Risks in Patients with Primary Prevention Implantable Cardioverters Defibrillators: Global Electrical Heterogeneity and Clinical Outcomes (GEHCO) Study
    Jonathan W. Waks, Kazi T. Haq, Christine Tompkins, Albert J. Rogers, Ashkan Ehdaie, Aron Bender, Jessica Minnier, Khidir Dalouk, Stacey Howell, Achille Peiris, Merritt Raitt, Sanjiv M. Narayan, Sumeet S. Chugh, Larisa G. Tereshchenko
    medRxiv 2020.12.16.20248369; doi: https://doi.org/10.1101/2020.12.16.20248369
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Competing Risks in Patients with Primary Prevention Implantable Cardioverters Defibrillators: Global Electrical Heterogeneity and Clinical Outcomes (GEHCO) Study
    Jonathan W. Waks, Kazi T. Haq, Christine Tompkins, Albert J. Rogers, Ashkan Ehdaie, Aron Bender, Jessica Minnier, Khidir Dalouk, Stacey Howell, Achille Peiris, Merritt Raitt, Sanjiv M. Narayan, Sumeet S. Chugh, Larisa G. Tereshchenko
    medRxiv 2020.12.16.20248369; doi: https://doi.org/10.1101/2020.12.16.20248369

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Cardiovascular Medicine
    Subject Areas
    All Articles
    • Addiction Medicine (70)
    • Allergy and Immunology (168)
    • Anesthesia (51)
    • Cardiovascular Medicine (455)
    • Dentistry and Oral Medicine (83)
    • Dermatology (55)
    • Emergency Medicine (159)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
    • Epidemiology (5294)
    • Forensic Medicine (3)
    • Gastroenterology (198)
    • Genetic and Genomic Medicine (760)
    • Geriatric Medicine (80)
    • Health Economics (214)
    • Health Informatics (702)
    • Health Policy (362)
    • Health Systems and Quality Improvement (224)
    • Hematology (100)
    • HIV/AIDS (165)
    • Infectious Diseases (except HIV/AIDS) (5934)
    • Intensive Care and Critical Care Medicine (367)
    • Medical Education (105)
    • Medical Ethics (25)
    • Nephrology (83)
    • Neurology (772)
    • Nursing (43)
    • Nutrition (135)
    • Obstetrics and Gynecology (146)
    • Occupational and Environmental Health (234)
    • Oncology (481)
    • Ophthalmology (153)
    • Orthopedics (39)
    • Otolaryngology (97)
    • Pain Medicine (39)
    • Palliative Medicine (20)
    • Pathology (141)
    • Pediatrics (223)
    • Pharmacology and Therapeutics (138)
    • Primary Care Research (99)
    • Psychiatry and Clinical Psychology (865)
    • Public and Global Health (2035)
    • Radiology and Imaging (354)
    • Rehabilitation Medicine and Physical Therapy (159)
    • Respiratory Medicine (287)
    • Rheumatology (94)
    • Sexual and Reproductive Health (74)
    • Sports Medicine (77)
    • Surgery (110)
    • Toxicology (25)
    • Transplantation (29)
    • Urology (39)